Sido Muncul PT (SIDO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sido Muncul PT (SIDO) has a cash flow conversion efficiency ratio of 0.131x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp409.72 Billion ≈ $24.01 Million USD) by net assets (Rp3.12 Trillion ≈ $182.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SIDO net asset quality score to measure how much of total assets are equity-financed.
Sido Muncul PT - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Sido Muncul PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Sido Muncul PT to evaluate the quality of earnings relative to operating cash generation.
Sido Muncul PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sido Muncul PT ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ciputra Development Tbk
JK:CTRA
|
0.004x |
|
Feitian Technologies Co Ltd
SHE:300386
|
0.001x |
|
Climb Bio Inc
NASDAQ:CLYM
|
-0.097x |
|
Warteck Invest Ltd
SW:WARN
|
0.021x |
|
Clarity Pharmaceuticals Ltd
AU:CU6
|
-0.205x |
|
AMN Healthcare Services Inc
NYSE:AMN
|
0.035x |
|
Zhejiang Xinao Textiles Inc
SHG:603889
|
0.064x |
|
Hangzhou Anysoft Information Technology Co Ltd
SHE:300571
|
0.066x |
Annual Cash Flow Conversion Efficiency for Sido Muncul PT (2010–2025)
The table below shows the annual cash flow conversion efficiency of Sido Muncul PT from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see SIDO market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Rp3.12 Trillion ≈ $182.85 Million |
Rp1.25 Trillion ≈ $73.44 Million |
0.402x | +21.73% |
| 2024-12-31 | Rp3.49 Trillion ≈ $204.37 Million |
Rp1.15 Trillion ≈ $67.44 Million |
0.330x | +5.87% |
| 2023-12-31 | Rp3.39 Trillion ≈ $198.40 Million |
Rp1.06 Trillion ≈ $61.84 Million |
0.312x | -1.67% |
| 2022-12-31 | Rp3.51 Trillion ≈ $205.41 Million |
Rp1.11 Trillion ≈ $65.11 Million |
0.317x | -8.25% |
| 2021-12-31 | Rp3.47 Trillion ≈ $203.40 Million |
Rp1.20 Trillion ≈ $70.28 Million |
0.346x | +7.47% |
| 2020-12-31 | Rp3.22 Trillion ≈ $188.78 Million |
Rp1.04 Trillion ≈ $60.69 Million |
0.321x | +17.73% |
| 2019-12-31 | Rp3.06 Trillion ≈ $179.58 Million |
Rp836.91 Billion ≈ $49.04 Million |
0.273x | +7833.63% |
| 2018-12-31 | Rp2.90 Trillion ≈ $170.08 Million |
Rp9.99 Billion ≈ $585.43K |
0.003x | -2.25% |
| 2017-12-31 | Rp2.90 Trillion ≈ $169.69 Million |
Rp10.20 Billion ≈ $597.50K |
0.004x | -44.67% |
| 2016-12-31 | Rp2.76 Trillion ≈ $161.60 Million |
Rp17.55 Billion ≈ $1.03 Million |
0.006x | +3.12% |
| 2015-12-31 | Rp2.60 Trillion ≈ $152.25 Million |
Rp16.04 Billion ≈ $939.65K |
0.006x | +124.28% |
| 2014-12-31 | Rp2.63 Trillion ≈ $154.38 Million |
Rp7.25 Billion ≈ $424.82K |
0.003x | +48.17% |
| 2013-12-31 | Rp2.63 Trillion ≈ $153.84 Million |
Rp4.88 Billion ≈ $285.71K |
0.002x | +133.65% |
| 2012-12-31 | Rp1.30 Trillion ≈ $76.45 Million |
Rp1.04 Billion ≈ $60.76K |
0.001x | -59.05% |
| 2011-12-31 | Rp535.34 Billion ≈ $31.37 Million |
Rp1.04 Billion ≈ $60.88K |
0.002x | -55.18% |
| 2010-12-31 | Rp346.41 Billion ≈ $20.30 Million |
Rp1.50 Billion ≈ $87.89K |
0.004x | -- |
About Sido Muncul PT
PT Industri Jamu dan Farmasi Sido Muncul Tbk provides herbal medicines, cosmetics, and foods and beverage products in Indonesia. The company operates through three segments: Herbal Medicine and Supplements; Food and Beverage; and Pharmacy. It also offers medicine products comprising ethical/prescriptions and OTCs; herbal products, such as traditional herbals, food and beverages, herbal medicines,… Read more